Oct 13, 2026 FRONTEO’s Medical Paper Search AI “KIBIT Amanogawa” Adopted by Suntory Global Innovation Center Leveraging Insights from Medical and Life Science for Research in the Food and Health Sectors
Oct 7, 2026 FRONTEO and ER Stress Research Institute Launch a Project to Discover Biomarkers for Patient Stratification Using Drug Discovery AI Factory Aiming to Create Innovative Pharmaceuticals by Combining AI-Driven Drug Discovery with Research on Unfolded Protein Response, a Field Associated with Potential Candidates for the Nobel Prize in Physiology or Medicine
Jul 23, 2026 FRONTEO Joins AMED’s “Dementia Research and Development Project” with Oita University and Beppu City Developing and Evaluating a New Model Using the Equation-Driven AI "KIBIT" for the Early Detection of Alzheimer's Disease, Which Begins Approximately 20 Years Before Onset— Demonstrated Through a Cohort Study of Approximately 800 Beppu Residents —
Jul 16, 2026 FRONTEO and Santen Pharmaceutical Launch Second Co-creation Project Driving Pipeline Expansion in the Ophthalmology Field Using the AI-powered Drug Discovery Support Service "Drug Discovery AI Factory"
Jul 14, 2026 FRONTEO and Daiichi Sankyo Develop Predictive Model to Automatically Extract Toxicological Interpretations from Toxicity Test Reports Results presented at the 53rd Annual Meeting of the Japanese Society of Toxicology, utilizing the AI-driven drug discovery support service "Drug Discovery AI Factory"
Jul 7, 2026 FRONTEO Launches Research Support Program to Provide “KIBIT Amanogawa” Medical Paper Search AI to Universities and Research Institutions for One Year Launches “KIBIT Amanogawa for Academia Program” to Support Academic Research; Up to 10 Projects to Be Selected to Accelerate the Creation of Innovative Pharmaceuticals Originating in Japan
Jun 30, 2026 Masahiro Morimoto, President & CEO of FRONTEO, Delivers a Lecture at American University in Washington, D.C. Highlights the Value of Human-Centered AI and the Competitive Advantage of “KIBIT” in Supporting Scientific Discovery
Jun 2, 2026 Morimoto, CEO, Delivers Special Lecture at “Growth Strategy for Healthcare Annual Forum 2026,” Attended by Nobel Laureates, Ministers, and 500 CEOs, Leaders from Industry, Academia, and Government
May 28, 2026 FRONTEO and SCOHIA PHARMA Sign Agreement to Explore New Indications Using the AI Drug Discovery Support Service “DDAIF”
May 13, 2026 The University of Oklahoma confirms inhibition of cell proliferation with a novel candidate target molecule for pancreatic cancer discovered by FRONTEO's AI drug discovery support service, Drug Discovery AI Factory Aiming to develop drugs that meet unmet medical needs by advancing to animal testing in the future
May 13, 2026 FRONTEO Opens KIBIT AI Biology Lab, a Center for AI Drug Discovery Major update of the AI drug discovery support service Drug Discovery AI Factory and full-scale operation of the system that handles the upstream of the drug discovery value chain
Apr 27, 2026 FRONTEO and Science Tokyo establish industry-academia Collaborative Research Cluster for AI-driven drug discovery Combining the AI drug discovery support service, Drug Discovery AI Factory, with the technological and research capabilities of academia to strengthen Japan's drug discovery capabilities through close collaboration between dry and wet research
